Search

Your search keyword '"Pedersen, I.S."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Pedersen, I.S." Remove constraint Author: "Pedersen, I.S."
40 results on '"Pedersen, I.S."'

Search Results

1. Clinical, splicing and functional analysis to classify BRCA2 exon 3 variants

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

6. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

7. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

9. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

10. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

11. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

12. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

13. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

14. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.

15. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

16. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

17. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

18. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

20. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

21. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

22. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

23. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

24. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

25. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

26. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

27. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

28. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

29. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

30. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

31. Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

32. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

34. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

35. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

36. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.

37. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

38. ECEL1 mutation causes fetal arthrogryposis multiplex congenita.

Catalog

Books, media, physical & digital resources